Ansbert Gadicke, 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 113,558 shares at $27.54 ($3.1M) on 2021-09-22, disclosed to the SEC on 2021-09-23.
Open-market sale of $3.1M ITOS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.47 | 32,858 | $903K | 28.9% |
| 2 | $27.47 | 32,858 | $903K | 28.9% |
| 3 | $27.54 | 23,921 | $659K | 21.1% |
| 4 | $27.54 | 23,921 | $659K | 21.1% |
| Total | $27.50 avg | 113,558 | $3.1M | 100% |
| Filing → |
| ITOS | SELL | 2022-01-06 | $20.9M | — | Filing → |
| ITOS | SELL | 2021-10-14 | $5.2M | — | Filing → |
| ITOS | SELL | 2021-10-05 | $2.2M | — | Filing → |